Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    AGY.L Forward P/E

    As of 2025-07-10, the Forward P/E of Allergy Therapeutics PLC (AGY.L) is N/A.

    Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

    AGY.L Forward P/E - Peers Comparison
    TickerNameValue
    ACPH.BRAcacia Pharma Group PLC-
    ADVIC.PAAdvicenne SA-
    AMYT.LAmryt Pharma PLC-
    CLBIO.STCorline Biomedical AB22.94
    EAH.LECO Animal Health Group PLC3,806.24
    ENZY.STEnzymatica AB (publ)-
    ERMA.STEnorama Pharma AB-
    FCM.MIFriulchem SpA-
    GRD1R.RGGrindeks AS-
    HYL.BRHyloris Pharmaceuticals SA-
    IBT B.STInfant Bacterial Therapeutics AB-
    INDEX.STInDex Pharmaceuticals Holding AB-
    IRLAB A.STIRLAB Therapeutics AB-
    KDEV.STKarolinska Development AB-
    LAVI.ATLavipharm SA-
    LIPI.STLipidor AB-
    MARI.VIMarinomed Biotech AG-
    MOB.STMoberg Pharma AB (publ)-
    NUTEX.BDNutex Befektetesi Nyrt-
    OAT.WAOncoarendi Therapeutics SA0.54
    OLF1R.RGOlainfarm AS13.19
    ORX.STOrexo AB-
    OVB.LOvoca Bio PLC-
    PHO.OLPhotocure ASA40.09
    PRL.MIPierrel SpA143.98
    RLS.STRLS Global AB-
    SHE.MIShedir Pharma Srl Unipersonale8.78
    VISTN.OLVistin Pharma ASA-
    Tickers added to watchlist